Revelation Partners supports Rosetta's acquisition of seven biotech assets

Revelation Partners backed Rosetta Capital's acquisition of seven biotech assets from Schroder UK Public Private Trust.

30 March 2021•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles